Lancet 388 (10063): 2997-3005, 2016.[PUBMED Abstract] Osborne CK, Pippen J, Jones SE, et al.: Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.
J Clin Oncol 20 (16): 3386-95, 2002.[PUBMED Abstract] Howell A, Robertson JF, Quaresma Albano J, et al.: Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment.
J Clin Oncol 20 (16): 3396-403, 2002.[PUBMED Abstract] Henderson IC: A rose is no longer a rose.